1De Witte T,Hermans J,Vossen J,et al.Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias:a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).Br J Haematol,2000,110:620～630.
2Ordemann R,Hutchinson R,Friedman J,et al.Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease.J Clin Invest,2002,109:1249～1256.
3Mcsweeney PA,Niederwieser D,Shizuru JA,et al.Hematopoietic cell transplantation in older patients with hematologic malignancies:replacing high-dose cytotoxic therapy with graft-versustumor effects.Blood,2001,97:3390～3400.
4Giralt S,Thall PF,Khouri I,et al.Melphalan and purine analog-containing preparative regimens:reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.Blood,2001,97:631～637.
5Gluckman E,Rocha V,Boyer-Chammard A,et al.Outcome of cord blood transplantation from related and unrelated donors.N Engl J Med.1997,337:373～381.
6Rubinstein P,Carrier C,Scaradavou A,et al.Outcomes among 562 recipients of placental blood transplants from unrelated donors.N Engl J Med,1998,339:1565～1577.
